- Home
- MLSS vs CLSD Comparison
MLSS vs CLSD Comparison
Compare MLSS & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLSS
- CLSD
- Stock Information
- Founded
- MLSS 1989
- CLSD 2011
- Country
- MLSS United States
- CLSD United States
- Employees
- MLSS N/A
- CLSD N/A
- Industry
- MLSS Industrial Specialties
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- MLSS Health Care
- CLSD Health Care
- Exchange
- MLSS Nasdaq
- CLSD Nasdaq
- Market Cap
- MLSS 50.0M
- CLSD 59.1M
- IPO Year
- MLSS 1995
- CLSD 2016
- Fundamental
- Price
- MLSS $0.67
- CLSD $0.87
- Analyst Decision
- MLSS Buy
- CLSD Strong Buy
- Analyst Count
- MLSS 1
- CLSD 4
- Target Price
- MLSS $1.25
- CLSD $4.75
- AVG Volume (30 Days)
- MLSS 88.0K
- CLSD 179.1K
- Earning Date
- MLSS 08-13-2025
- CLSD 08-11-2025
- Dividend Yield
- MLSS N/A
- CLSD N/A
- EPS Growth
- MLSS N/A
- CLSD N/A
- EPS
- MLSS N/A
- CLSD N/A
- Revenue
- MLSS $8,613,503.00
- CLSD $3,764,000.00
- Revenue This Year
- MLSS $29.14
- CLSD $60.52
- Revenue Next Year
- MLSS $20.19
- CLSD $88.28
- P/E Ratio
- MLSS N/A
- CLSD N/A
- Revenue Growth
- MLSS N/A
- CLSD N/A
- 52 Week Low
- MLSS $0.57
- CLSD $0.70
- 52 Week High
- MLSS $1.39
- CLSD $1.65
- Technical
- Relative Strength Index (RSI)
- MLSS 35.08
- CLSD 58.96
- Support Level
- MLSS $0.61
- CLSD $0.80
- Resistance Level
- MLSS $0.73
- CLSD $0.88
- Average True Range (ATR)
- MLSS 0.07
- CLSD 0.04
- MACD
- MLSS -0.00
- CLSD 0.01
- Stochastic Oscillator
- MLSS 38.71
- CLSD 84.82
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.